- Home
- TNON vs CELZ Comparison
TNON vs CELZ Comparison
Compare TNON & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- CELZ
- Stock Information
- Founded
- TNON 2012
- CELZ 1998
- Country
- TNON United States
- CELZ United States
- Employees
- TNON N/A
- CELZ N/A
- Industry
- TNON Medical Specialities
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- CELZ Health Care
- Exchange
- TNON Nasdaq
- CELZ Nasdaq
- Market Cap
- TNON 11.5M
- CELZ 10.4M
- IPO Year
- TNON 2022
- CELZ N/A
- Fundamental
- Price
- TNON $1.14
- CELZ $3.09
- Analyst Decision
- TNON Strong Buy
- CELZ
- Analyst Count
- TNON 2
- CELZ 0
- Target Price
- TNON $5.50
- CELZ N/A
- AVG Volume (30 Days)
- TNON 987.5K
- CELZ 169.9K
- Earning Date
- TNON 11-13-2025
- CELZ 11-07-2025
- Dividend Yield
- TNON N/A
- CELZ N/A
- EPS Growth
- TNON N/A
- CELZ N/A
- EPS
- TNON N/A
- CELZ N/A
- Revenue
- TNON $3,233,000.00
- CELZ $6,000.00
- Revenue This Year
- TNON $17.85
- CELZ N/A
- Revenue Next Year
- TNON $85.60
- CELZ N/A
- P/E Ratio
- TNON N/A
- CELZ N/A
- Revenue Growth
- TNON N/A
- CELZ N/A
- 52 Week Low
- TNON $0.85
- CELZ $1.69
- 52 Week High
- TNON $5.85
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- TNON 43.47
- CELZ 45.24
- Support Level
- TNON $1.11
- CELZ $2.77
- Resistance Level
- TNON $1.30
- CELZ $3.34
- Average True Range (ATR)
- TNON 0.05
- CELZ 0.47
- MACD
- TNON -0.00
- CELZ -0.05
- Stochastic Oscillator
- TNON 15.79
- CELZ 17.24
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.